162. Identifying Determinants of Therapeutic Switch to Linezolid among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

BACKGROUND: In order to target future randomized controlled trials (RCT) of treatment of methicillin-resistant S aureus bloodstream infections (MRSA BSI), it will be important to understand the drivers of antibiotic selection. We aimed to determine factors associated with switching from vancomycin t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Rajeshwari, Schweizer, Marin L, Perencevich, Eli N, Livorsi, Daniel J, Goto, Michihiko, Alexander, Bruce, Beck, Brice, Richardson, Kelly, Puig-Asensio, Mireia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809968/
http://dx.doi.org/10.1093/ofid/ofz360.237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809968/
http://dx.doi.org/10.1093/ofid/ofz360.237

Ejemplares similares